Mediantechnologies Stock
€3.25
Your prediction
Mediantechnologies Stock
Pros and Cons of Mediantechnologies in the next few years
Pros
Cons
Performance of Mediantechnologies vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Mediantechnologies | -1.520% | - | - | - | - | - | - |
Coheris S.A. Inh. | - | -0.769% | 9.787% | 66.452% | 7.950% | 173.016% | 184.298% |
Acteos | 1.180% | -1.167% | 4.098% | -13.605% | 9.013% | -57.807% | 3.252% |
Netgem S.A. | 1.930% | -1.684% | 4.241% | -10.192% | -5.274% | -23.128% | -20.511% |
Comments
News
Median Technologies to Participate in the TD Cowen’s 44th Annual Health Care Conference
Regulatory News:
Median Technologies (FR0011049824, ALMDT, PEA/SME eligible) (Paris:ALMDT), will be participating in the TD Cowen’s 44th Annual Health Care Conference, taking place on March 4 –
Median Technologies to Participate and Speak at the 2024 European Congress of Radiology (ECR), February 28 – March 3, Vienna, Austria
Regulatory News:
Median Technologies (FR0011049824, ALMDT, PEA/SME eligible) announces today that the Company will be participating and speaking at the premier European radiology conference, the
Median Technologies Reports 2023 Revenue and Summarizes 2024 Strategic Outlook
Regulatory News:
Median Technologies (FR0011049824, ALMDT, PEA/SME eligible) announces its 2023 revenue, outlining both its strategic outlook and key milestones for 2024.
Fredrik Brag, Chief